Maccura Biotechnology Co Ltd (300463) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.023x

Based on the latest financial reports, Maccura Biotechnology Co Ltd (300463) has a cash flow conversion efficiency ratio of 0.023x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥148.82 Million ≈ $21.78 Million USD) by net assets (CN¥6.38 Billion ≈ $933.50 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 300463 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Maccura Biotechnology Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Maccura Biotechnology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Maccura Biotechnology Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Maccura Biotechnology Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Shanghai Pudong Road & Bridge Construction Co Ltd SHG:600284	0.035x
Ridley Corporation Ltd AU:RIC	0.154x
Weihai Guangtai Airport Equipment Co Ltd SHE:002111	0.109x
Shandong Xinneng Taishan Power Generation Co Ltd SHE:000720	-0.057x
Ferrari Group PLC AS:FERGR	0.069x
Hunan Jiudian Pharmaceutical Co Ltd SHE:300705	0.068x
PennantPark Floating Rate Capital Ltd NYSE:PFLT	-0.009x
Southern Missouri Bancorp Inc NASDAQ:SMBC	0.051x

Annual Cash Flow Conversion Efficiency for Maccura Biotechnology Co Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Maccura Biotechnology Co Ltd from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see 300463 market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥6.31 Billion ≈ $922.72 Million	CN¥602.33 Million ≈ $88.14 Million	0.096x	-3.19%
2024-12-31	CN¥6.42 Billion ≈ $939.98 Million	CN¥633.80 Million ≈ $92.74 Million	0.099x	-28.48%
2023-12-31	CN¥6.61 Billion ≈ $967.46 Million	CN¥912.09 Million ≈ $133.47 Million	0.138x	+6.83%
2022-12-31	CN¥6.53 Billion ≈ $955.50 Million	CN¥843.22 Million ≈ $123.39 Million	0.129x	-63.72%
2021-12-31	CN¥4.54 Billion ≈ $664.60 Million	CN¥1.62 Billion ≈ $236.57 Million	0.356x	+30.32%
2020-12-31	CN¥4.01 Billion ≈ $586.12 Million	CN¥1.09 Billion ≈ $160.09 Million	0.273x	+97.80%
2019-12-31	CN¥3.33 Billion ≈ $486.94 Million	CN¥459.52 Million ≈ $67.24 Million	0.138x	+104.03%
2018-12-31	CN¥2.86 Billion ≈ $419.24 Million	CN¥193.91 Million ≈ $28.37 Million	0.068x	+123.77%
2017-12-31	CN¥2.61 Billion ≈ $382.37 Million	CN¥79.03 Million ≈ $11.57 Million	0.030x	+40.04%
2016-12-31	CN¥2.28 Billion ≈ $334.12 Million	CN¥49.32 Million ≈ $7.22 Million	0.022x	+30.20%
2015-12-31	CN¥2.00 Billion ≈ $292.73 Million	CN¥33.18 Million ≈ $4.86 Million	0.017x	-88.58%
2014-12-31	CN¥792.05 Million ≈ $115.90 Million	CN¥115.09 Million ≈ $16.84 Million	0.145x	-10.73%
2013-12-31	CN¥604.48 Million ≈ $88.46 Million	CN¥98.39 Million ≈ $14.40 Million	0.163x	-35.02%
2012-12-31	CN¥442.98 Million ≈ $64.82 Million	CN¥110.96 Million ≈ $16.24 Million	0.250x	-8.71%
2011-12-31	CN¥311.77 Million ≈ $45.62 Million	CN¥85.55 Million ≈ $12.52 Million	0.274x	--

About Maccura Biotechnology Co Ltd

SHE:300463 China Diagnostics & Research

Market Cap

$742.36 Million

CN¥5.07 Billion CNY

Market Cap Rank

#10400 Global

#2849 in China

Share Price

CN¥8.39

Change (1 day)

+0.12%

52-Week Range

CN¥8.38 - CN¥14.20

All Time High

CN¥59.01